ODOMZO® (sonidegib) | Efficacy Data
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Visualization of efficacy endpoints in oncology clinical trials
ORR (Objective Response Rate) and related statistics – Part 1
Efficacy | BALVERSA® (erdafitinib) HCP
Confirmed ORR | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
ORR (Objective Response Rate) and related statistics – Part 1
Response Rates for Waldenström Macroglobulinemia Improve With Use of New First-Line, Better-Tolerated Treatments - U.S. Medicine
Efficacy I PLUVICTO
Efficacy Data: Overall Response Rate | VITRAKVI® (larotrectinib)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition | NEJM
Updated Data for Indoximod Plus KEYTRUDA® (pembrolizumab) Demonstrate Improvement of Response Rate for Patients with Advanced Melanoma | Business Wire
TECARTUS® Efficacy - Response Data for R/R MCL
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
MZL Efficacy Data: Overall Response Rates | IMBRUVICA® | HCP
The overall response rate | Download Table
Study 1104 Overall Response Rate: R/R MCL | IMBRUVICA® (ibrutinib) HCP
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Overall response rate | Download Table
ORR - "Overall Response Rate" by AcronymsAndSlang.com
BRAFTOVI + cetuximab | Overall Response Rate | ORR | BEACON CRC
Durable Responses Are Observed With Cemiplimab in mBCC
Pecoma Clinical Trial Efficacy Data | FYARRO | HCP Site
Overall Response Rate of 76% in Advanced Melanoma Patients
